Schiopu, E., Chatterjee, S., Hsu, V., Flor, A., Cimbora, D., Patra, K., . . . Herbst, R. (2016). Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: A phase I, randomized, placebo-controlled, escalating single-dose study. Arthritis Res Ther.
Citação norma ChicagoSchiopu, Elena, et al. "Safety and Tolerability of an Anti-CD19 Monoclonal Antibody, MEDI-551, in Subjects With Systemic Sclerosis: A Phase I, Randomized, Placebo-controlled, Escalating Single-dose Study." Arthritis Res Ther 2016.
Citação norma MLASchiopu, Elena, et al. "Safety and Tolerability of an Anti-CD19 Monoclonal Antibody, MEDI-551, in Subjects With Systemic Sclerosis: A Phase I, Randomized, Placebo-controlled, Escalating Single-dose Study." Arthritis Res Ther 2016.